National Center for PTSD
Honolulu, Hawaii, 96819, United States
NCT Number: NCT02041572
The study has two goals. First to develop a computer-based intervention meant to alter cognitive biases that contribute to ongoing PTSD symptoms. Second, we sought to pilot test the intervention in a small sample of veterans for feasibility and acceptability.
Looking for future studies?
Notify Me18 year–89 year
Male
Interventional
Not applicable
Honolulu, Hawaii, 96819, United States
Aim 1: Develop Attentional Bias Retraining protocol (Phase 1)
Aim 2: Implement in pilot sample (Phase 2)
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants complete a computer-based intervention, which is designed to correct cognitive biases associated with PTSD by training to attend to neutral information rather than the trauma-related cue words.
Time frame: Change from Baseline and Post-treatment (1 month after last training session)
PCL-M assess the 17-cardinal symptoms of PTSD.
Time frame: Change from Baseline and Post-treatment (1 month after last training session)
Attentional bias scores represent participants cognitive bias to orient towards trauma-relevant information more quickly than neutral information.
Time frame: Change from Baseline and Post-treatment (1 month after last training session)
Participants filled out daily symptom log nightly
VA Pacific Islands Health Care System
Fed
Acronym: ABR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04763681
COVID-19, Coronaviridae Infections
Toronto, Ontario, Canada
View Trial DetailsNCT05862467
Autism, Autism Spectrum Disorder
Laramie, Wyoming, United States
View Trial DetailsNCT06130501
Chemically-Induced Disorders, Mental Disorders
Cape Girardeau, Missouri, United States
View Trial DetailsNCT05280691
Anxiety Disorders, Behavior
Winterthur, Canton of Zurich, Switzerland
View Trial Details